Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Micah Steffek

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|February 7, 2009
Structural and functional analysis of a C3b-specific antibody that selectively inhibits the alternative pathway of complementKenneth J Katschke, Scott Stawicki, Jianping Yin, et al.
Nature Chemical Biology|June 12, 2012
Allosteric peptides bind a caspase zymogen and mediate caspase tetramerizationKaren Stanger, Micah Steffek, Lijuan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2013
Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug designXiaojing Wang, Steven Magnuson, Rich Pastor, et al.
Nature Structural & Molecular Biology|January 29, 2020
Negative regulation of RAF kinase activity by ATP is overcome by 14-3-3-induced dimerizationNicholas P D Liau, Timothy J Wendorff, John G Quinn, et al.
Science (New York, N.Y.)|February 22, 2020
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximabLionel Rougé, Nancy Chiang, Micah Steffek, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Conformational dynamics control ubiquitin-deubiquitinase interactions and influence in vivo signalingAaron H Phillips, Yingnan Zhang, Christian N Cunningham, et al.
Chemmedchem|November 22, 2013
Tailoring small molecules for an allosteric site on procaspase-6Jeremy Murray, Anthony M Giannetti, Micah Steffek, et al.
ACS Infectious Diseases|December 16, 2017
Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted MetabolomicsChristopher M Rath, Bret M Benton, Javier de Vicente, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2013
Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitorsSharada Labadie, Kathy Barrett, Wade S Blair, et al.
The Journal of Experimental Medicine|June 6, 2007
A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritisKenneth J Katschke, Karim Y Helmy, Micah Steffek, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|February 7, 2009
Structural and functional analysis of a C3b-specific antibody that selectively inhibits the alternative pathway of complementKenneth J Katschke, Scott Stawicki, Jianping Yin, et al.
Nature Chemical Biology|June 12, 2012
Allosteric peptides bind a caspase zymogen and mediate caspase tetramerizationKaren Stanger, Micah Steffek, Lijuan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2013
Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug designXiaojing Wang, Steven Magnuson, Rich Pastor, et al.
Nature Structural & Molecular Biology|January 29, 2020
Negative regulation of RAF kinase activity by ATP is overcome by 14-3-3-induced dimerizationNicholas P D Liau, Timothy J Wendorff, John G Quinn, et al.
Science (New York, N.Y.)|February 22, 2020
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximabLionel Rougé, Nancy Chiang, Micah Steffek, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Conformational dynamics control ubiquitin-deubiquitinase interactions and influence in vivo signalingAaron H Phillips, Yingnan Zhang, Christian N Cunningham, et al.
Chemmedchem|November 22, 2013
Tailoring small molecules for an allosteric site on procaspase-6Jeremy Murray, Anthony M Giannetti, Micah Steffek, et al.
ACS Infectious Diseases|December 16, 2017
Optimization of CoaD Inhibitors against Gram-Negative Organisms through Targeted MetabolomicsChristopher M Rath, Bret M Benton, Javier de Vicente, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2013
Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitorsSharada Labadie, Kathy Barrett, Wade S Blair, et al.
The Journal of Experimental Medicine|June 6, 2007
A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritisKenneth J Katschke, Karim Y Helmy, Micah Steffek, et al.
Pageof 4